GlassScriptPhysician profile
Nathan Edwin Lesley
NPI 1982836433
$97,713.94
in general payments reported to CMS, 2019-2025
29 companies · $6,220 in 2025
The $6,220 reported for 2025 was more than what 84% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $18K · 2021: $11K · 2022: $14K · 2023: $16K · 2024: $18K · 2025: $6,220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Consulting Fee: $12K · Travel and Lodging: $5,779 · Food and Beverage: $3,617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,900.00 |
| Consulting Fee | $11,518.20 |
| Travel and Lodging | $5,779.21 |
| Food and Beverage | $3,616.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $44,907.76 | 2019-2025 | Acumed, Osteomed, Innate Implant |
| Microaire Surgical Instruments LLC | $17,700.00 | 2021-2022 | |
| Arthrex, INC. | $13,992.41 | 2019-2023 | Distal Extremities Implants Soft Tissue H&W Mini Tightropes |
| Exsomed Corporation | $9,298.09 | 2019-2022 | |
| Medartis INC. | $4,704.36 | 2024-2025 | Aptus |
| Pylant Medical | $3,032.64 | 2019-2024 | |
| Anika Therapeutics, INC. | $1,399.86 | 2021-2022 | |
| Sonex Health, INC. | $783.51 | 2023 | Sx-One Microknife |
| Stryker Corporation | $442.98 | 2019-2025 | Mako, Hoffmann |
| Osteomed LLC | $316.00 | 2020 | |
| Trice Medical, INC. | $183.87 | 2023 | |
| Amgen INC. | $157.44 | 2024-2025 | Krystexxa |
| Integra Lifesciences Corporation | $155.73 | 2022 | |
| Axogen | $154.60 | 2019 | |
| Acera Surgical, INC. | $107.09 | 2021-2025 | Restrata Wound Matrix |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $58.35 | 2023 | Krystexxa |
| Endo Pharmaceuticals INC. | $55.08 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $49.17 | 2019 | |
| Hydrocision, INC. | $41.45 | 2022 | |
| Ossio INC | $29.14 | 2022 | |
| Orthofix Medical, INC. | $26.25 | 2022-2025 | Physio-Stim |
| Genentech USA, INC. | $16.95 | 2020 | |
| Depuy Synthes Sales INC. | $16.54 | 2023 | Gii, Microfix Quickanchor Ethibond, Quickanchor Ethibond |
| Dynasplint Systems INC. | $15.97 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $15.69 | 2019 | |
| Novo Nordisk INC | $14.63 | 2020 | |
| Abbott Laboratories | $13.41 | 2021 | |
| Checkpoint Surgical, INC | $12.55 | 2022 | |
| Nevro Corp. | $12.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Lesley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.